Gregory Abel

I am a hematologic oncologist and cancer care delivery researcher. The focus of my research is to improve quality of life (QOL) and quality of care for patients with hematologic malignancies. I have designed, successfully applied for funding, and published many studies relating to health services and outcomes for patients with blood cancers. For example, I led the international validation of a QOL scale developed for patients with myelodysplastic syndromes (MDS), the QUALMS, which has since been incorporated into several clinical trials and registries for patients with that disease. Additionally, I led a study using QOL assessment to help with transfusion decisions for patients with MDS, which is highly relevant to the final aim of my HCL 2030 proposal. I would be delighted to lead the team to complete the aims of the proposed research; moreover, the project will satisfy my goal to bring my research expertise to bear on the care that I provide for patients with hairy cell leukemia.